Design, synthesis, and evaluation of novel heteroaryldihydropyrimidine derivatives as non‐nucleoside hepatitis B virus inhibitors by exploring the solvent‐exposed region

2020 ◽  
Vol 95 (6) ◽  
pp. 567-583 ◽  
Author(s):  
Ji Yu ◽  
Haiyong Jia ◽  
Xiaowei Guo ◽  
Samuel Desta ◽  
Shuo Zhang ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Design Synthesis ◽  
Exposed Region ◽  
B Virus

Design, Synthesis and Biological Evaluation of Caudatin Analogs as Potent Hepatitis B Virus Inhibitors

2015 ◽  
Vol 11 (2) ◽  
pp. 165-179 ◽  
Author(s):  
Li-Jun Wang ◽  
Hao Chen ◽  
Yun-Bao Ma ◽  
Xiao-Yan Huang ◽  
Chang-An Geng ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Biological Evaluation ◽  
Design Synthesis ◽  
B Virus ◽  
Synthesis And Biological Evaluation

Design, synthesis and evaluation of heteroaryldihydropyrimidine analogues bearing spiro ring as hepatitis B virus capsid protein inhibitors

2021 ◽  
pp. 113780
Author(s):  
Yue Ma ◽  
Shujie Zhao ◽  
Yujie Ren ◽  
Srinivasulu Cherukupalli ◽  
Qilan Li ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Capsid Protein ◽  
Protein Inhibitors ◽  
Virus Capsid ◽  
Design Synthesis ◽  
B Virus ◽  
Virus Capsid Protein

Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors

2018 ◽  
Vol 144 ◽  
pp. 424-434 ◽  
Author(s):  
Jingying Qiu ◽  
Qineng Gong ◽  
Jian Gao ◽  
Wang Chen ◽  
Yinpeng Zhang ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Design Synthesis ◽  
B Virus

scholarly journals Design, Synthesis, and Biological Evaluation of Triazolo-pyrimidine Derivatives as Novel Inhibitors of Hepatitis B Virus Surface Antigen (HBsAg) Secretion

2011 ◽  
Vol 54 (16) ◽  
pp. 5660-5670 ◽  
Author(s):  
Wenquan Yu ◽  
Cally Goddard ◽  
Elizabeth Clearfield ◽  
Courtney Mills ◽  
Tong Xiao ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Surface Antigen ◽  
Biological Evaluation ◽  
Pyrimidine Derivatives ◽  
Design Synthesis ◽  
Virus Surface ◽  
Virus Surface Antigen ◽  
B Virus ◽  
Synthesis And Biological Evaluation

Design, synthesis and evaluation of pyrazole derivatives as non-nucleoside hepatitis B virus inhibitors

2016 ◽  
Vol 123 ◽  
pp. 202-210 ◽  
Author(s):  
Haiyong Jia ◽  
Fuxiang Bai ◽  
Na Liu ◽  
Xiaohong Liang ◽  
Peng Zhan ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Pyrazole Derivatives ◽  
Design Synthesis ◽  
B Virus

scholarly journals Design, synthesis, and molecular hybrids of caudatin and cinnamic acids as novel anti-hepatitis B virus agents

2012 ◽  
Vol 54 ◽  
pp. 352-365 ◽  
Author(s):  
Li-Jun Wang ◽  
Chang-An Geng ◽  
Yun-Bao Ma ◽  
Jie Luo ◽  
Xiao-Yan Huang ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Cinnamic Acids ◽  
Design Synthesis ◽  
B Virus ◽  
Molecular Hybrids

scholarly journals Design, Synthesis and Bioactive Evaluation of Oxime Derivatives of Dehydrocholic Acid as Anti-Hepatitis B Virus Agents

Molecules ◽  
2020 ◽  
Vol 25 (15) ◽  
pp. 3359
Author(s):  
Zhuocai Wei ◽  
Jie Tan ◽  
Xinhua Cui ◽  
Min Zhou ◽  
Yunhou Huang ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Positive Control ◽  
Docking Studies ◽  
Design Synthesis ◽  
Dehydrocholic Acid ◽  
B Virus ◽  
Effective Inhibition ◽  
Oxime Derivatives ◽  
Derivatives Of

Oxime derivatives of dehydrocholic acid and its esters were designed for anti-hepatitis B virus (HBV) drugs according to principles of assembling active chemical fragments. Twelve compounds were synthesized from dehydrocholic acid by esterification and oxime formation, and their anti-hepatitis B virus (HBV) activities were evaluated with HepG 2.2.15 cells. Results showed that 5 compounds exhibited more effective inhibition of HBeAg than positive control, among them 2b-3 and 2b-1 showed significant anti-HBV activities on inhibiting secretion of HBeAg (IC50 (2b-3) = 49.39 ± 12.78 μM, SI (2b-3) = 11.03; IC50 (2b-1) = 96.64 ± 28.99 μM, SI (2b-1) = 10.35) compared to the Entecavir (IC50 = 161.24 μM, SI = 3.72). Molecular docking studies showed that most of these compounds interacted with protein residues of heparan sulfate proteoglycan (HSPG) in host hepatocyte and bile acid receptor.

scholarly journals A Series of Oleanolic Acid Derivatives as Anti-Hepatitis B Virus Agents: Design, Synthesis, and in Vitro and in Vivo Biological Evaluation

Molecules ◽  
2016 ◽  
Vol 21 (4) ◽  
pp. 402 ◽  
Author(s):  
Wenqiang Yan ◽  
Chenze Zhang ◽  
Bi Li ◽  
Xin Xu ◽  
Miao Liang ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Oleanolic Acid ◽  
Biological Evaluation ◽  
Design Synthesis ◽  
B Virus

scholarly journals Design, Synthesis, and Bioactive Screen In Vitro of Cyclohexyl (E)-4-(Hydroxyimino)-4-Phenylbutanoates and Their Ethers for Anti-Hepatitis B Virus Agents

Molecules ◽  
2019 ◽  
Vol 24 (11) ◽  
pp. 2063 ◽  
Author(s):  
Xinhua Cui ◽  
Min Zhou ◽  
Jie Tan ◽  
Zhuocai Wei ◽  
Wanxing Wei ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Cell Line ◽  
Active Site ◽  
Docking Study ◽  
Design Synthesis ◽  
Ctl Epitope ◽  
B Virus ◽  
Hla A2.1

A series of oxime Cyclohexyl (E)-4-(hydroxyimino)-4-phenylbutanoates and their ethers were designed, synthesized, and evaluated for anti-hepatitis B virus (HBV) activities with HepG 2.2.15 cell line in vitro. Most of these compounds possessed anti-HBV activities, and among them, compound 4B-2 showed significant inhibiting effects on the secretion of HBsAg (IC50 = 63.85 ± 6.26 μM, SI = 13.41) and HBeAg (IC50 = 49.39 ± 4.17 μM, SI = 17.34) comparing to lamivudine (3TC) in HBsAg (IC50 = 234.2 ± 17.17 μM, SI = 2.2) and HBeAg (IC50 = 249.9 ± 21.51 μM, SI = 2.07). Docking study of these compounds binding to a protein residue (PDB ID: 3OX8) from HLA-A2 that with the immunodominant HBcAg18–27 epitope (HLA-A2.1- restricted CTL epitope) active site was carried out by using molecular operation environment (MOE) software. Docking results showed that behaviors of these compounds binding to the active site in HLA-A protein residue partly coincided with their behaviors in vitro anti-HBV active screening.

Sign in / Sign up

Export Citation Format

Share Document